Efficacy Comparison Between Weekly and Triweekly Regimens of Carboplatin-paclitaxel in Non-small Cell Lung Cancer
Aim:Around 40% of non-small cell lung cancers have stage 3b or 4 disease at the time of diagnosis. In the treatment, platinum-based therapy can still be used in patients who do not carry a driver mutation or who are not suitable for immunotherapy with advanced non-small cell lung cancers (NSCLC). Th...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Galenos Yayincilik
2023-09-01
|
Series: | Namık Kemal Tıp Dergisi |
Subjects: | |
Online Access: |
http://namikkemalmedj.com/archives/archive-detail/article-preview/efficacy-comparison-between-weekly-and-triweekly-r/62095
|